Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CYTH Cyclo Therapeutics

Watchlist
1.825
-0.075-3.95%
Trading Session  12/06 14:55 ET
High
1.895
Open
1.860
Turnover
146.77K
Low
1.770
Pre Close
1.900
Volume
80.02K
Market Cap
15.48M
P/E(TTM)
Loss
52wk High
5.120
Shares
8.48M
P/E(Static)
Loss
52wk Low
0.910
Float Cap
13.96M
Bid/Ask %
-33.33%
Historical High
17.750
Shs Float
7.65M
Volume Ratio
0.48
Historical Low
0.910
Dividend TTM
--
Div Yield TTM
--
P/B
2.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.05%
Amplitude
6.58%
Avg Price
1.834
Lot Size
1
Float Cap
13.96M
Bid/Ask %
-33.33%
Historical High
17.750
Shs Float
7.65M
Volume Ratio
0.48
Historical Low
0.910
Dividend TTM
--
P/B
2.76
Dividend LFY
--
Turnover Ratio
1.05%
Amplitude
6.58%
Avg Price
1.834
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
CEO: Mr. N. Scott Fine
Market: NASDAQ
Listing Date: 12/09/2020
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist